Joey and LABB Pitch Deck

1. • Headquarters Location
• Trump Tower 1
• 16001 Collins Avenue, Su 3202
• Sunny Isles Beach, FL 33160
• www.joeynewyork.com
• www.botoxlabb.com
• Symbol: OTC JOEY
• Key Management
• Joey Chancis, Founder/CEO
• Richard Roer, President
• Projected (FY) 2016 Revenues
• Over $12 Million

2. Investor Summary: JOEY NEW YORK®
(OTC – JOEY)
Joey New York ® Inc. is a diversified skin care and aesthetic services company. The Company has two
distinct divisions, The LABB, (LABB Aesthetic Beauty Bar) and the Joey New York® skin care and beauty
product line. There is a high degree of synergy between the skin care line and the LABB services. With
the decades of skincare experience the team at Joey has, it is only logical that they leverage their
experience by employing a new concept in the injectables market, (Botox® and Fillers). The concept is
called The LABB (L.A.B.B. Aesthetic Beauty Bar). This division services a large segment of a 13-Billion-
dollar market, that has grown 6,400% since 1997.
Joey is also preparing new collections for the cosmetic line. These products will be exclusively sold
through existing retail distribution channels and at all LABB locations. Some of these products are
specifically tailored to the needs of LABB clientele, to enhance, and protect the customers LABB
investment .
(FY) 2016 (FY) 2017 (FY) 2018 (FY) 2019 (FY) 2020 (FY) 2021
Revenue $ 12,148,113 $ 40,183,936 $ 80,367,872 $ 118,951,808 $ 157,535,744 $ 196,919,680
Cost of Sales $ 7,067,184 $ 22,830,400 $ 45,660,800 $ 67,456,200 $ 89,251,600 $ 111,564,000
Net Profit $ 5,080,929 $ 17,353,536 $ 34,707,072 $ 51,495,608 $ 68,284,144 $ 85,355,680
Outstanding
shares 27,848,898 30,000,000 35,000,000 40,000,000 45,000,000 50,000,000
Earnings per
share $ 0.18 $ 0.58 $ 0.99 $ 1.29 $ 1.52 $ 1.71
FY= Fiscal year

4. THE LABB OVERVIEW:
The mission of “The LABB” is to deliver the most exceptional client experience, and
results of beauty enhancement, through the use of cutting edge science, technology
and aesthetic craftsmanship from a most convenient platform. The LABB is poised to
become the foremost leader in aesthetic service delivery, by providing high quality
injectables, utilizing the most advanced available technologies, tailored to each
patient’s needs, at an affordable price.
By performing injectables exclusively, The LABB can streamline purchasing power, thus
driving down costs. This makes The LABB an attractive option, opposed to visiting a
much more expensive cosmetic surgeon.
The concept is simple. Excellent technicians, standardized training, multiple locations,
consistent branding, incredibly low overhead, state of the art facilities, with bulk
purchasing power.
With the “Baby Boomers” searching for a youthful look, Joey’s experience in the
cosmetic industry, and the LABB services, allows us to be uniquely positioned to
capture a large segment of this market.

5. The core of the LABB is their ability to specialize in facial aesthetics, providing top of
line products, administered by a master technician, within a high quality organization.
The east coast market represents the 2nd largest injectable filler market in the U.S.
(barely below California).
Over the next year there are 10 facilities identified to be opened, giving $5M in net
profit in the first 12 months.
Next year Joey plans to roll out another 5 facilities. This will total 15 facilities yielding
over $17M in net profit.
The pilot location in South Beach, Miami, has been opened since June. This location is
consistently fully booked. In July, a second Florida location opened, in Daytona Beach,
as well as a third location in Ft Lauderdale. Both “soft opened” and are cash flow
positive with growing customer bases.
Additional Florida LABB’s have been identified for Boca Raton, West Palm Beach,
Aventura as well as other cities. Negotiations are already underway for LABB’s in NY,
Arizona, California and Las Vegas.

9. ADDED VALUE
• Expertise and ability to combine medical and retail: Complete packages that combine
medical and retail in such a way that will become a powerhouse, dominating the aesthetic
beauty industry.
• Depth of knowledge of the markets and direct to consumer marketing: Two entities joining
together to create the said powerhouse dubbed The LABB. One entity bringing the depth of
both medical and retail knowledge, and the other with a large scope of both retail and direct
to consumer know how, which translates into money.
• Product purchasing power & reduced pricing: Because we have such a large purchasing
account, we are able to drive down the purchasing cost to us.
• Original Model Scheme: The only model on the market to date that focuses on one
objective, and is able to capitalize on the clients through a non traditional medical model,
rather focusing on a ”need” or “must have” retail platform. By doing this we are creating a
demand/supply for the aesthetic injecting market.

13. DISCLAIMER
• The financial information included in this presentation is preliminary, unaudited and subject
to revision upon completion of the Company's closing and audit processes. This financial
information has not been adjusted to reflect the outcome of any reorganization of the
company’s capital structure, the resolution or impairment of any pre‐petition obligations, and
does not reflect fresh start accounting which the company may be required to adopt. All
forward–looking statements attributable to the Company or persons acting on its behalf
apply only as of the date of this document, and are expressly qualified in their entirety by the
cautionary statements included elsewhere in this document. The financial projections are
preliminary and subject to change; the Company undertakes no obligation to update or revise
these forward–looking statements to reflect events or circumstances that arise after the date
made or to reflect the occurrence of unanticipated events. Inevitably, some assumptions will
not materialize, and unanticipated events and circumstances may affect the ultimate financial
results. Projections are inherently subject to substantial and numerous uncertainties and to a
wide variety of significant business, economic and competitive risks, and the assumptions
underlying the projections may be inaccurate in any material respect. Therefore, the actual
results achieved may vary significantly from the forecasts, and the variations may be
material.